Publication Date:
2017-04-22
Description:
Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment Blood Cancer Journal 7, e554 (April 2017). doi:10.1038/bcj.2017.31 Authors: M A Dimopoulos, A K Stewart, T Masszi, I Špička, A Oriol, R Hájek, L Rosiñol, D Siegel, G G Mihaylov, V Goranova-Marinova, P Rajnics, A Suvorov, R Niesvizky, A Jakubowiak, J San-Miguel, H Ludwig, S Ro, S Aggarwal, P Moreau & A Palumbo
Electronic ISSN:
2044-5385
Topics:
Medicine
Permalink